Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Mar;20(3):e5.
doi: 10.1634/theoncologist.2014-423.

In reply

Affiliations
Comment

In reply

Dario Baratti et al. Oncologist. 2015 Mar.

Abstract

The authors are currently conducting molecular and genetic research to identify new targets for therapeutic interventions and predictive biomarkers in pseudomyxoma peritonei. The final aim of these studies is to rationalize the choice of treatment, which remains an unmet clinical need.

PubMed Disclaimer

Comment on

References

    1. Overman MJ, Eng C, Matamoros A, et al. Challenges of efficacy assessments in pseudomyxoma peritonea. The Oncologist. 2015;20:335–336. - PMC - PubMed
    1. Pietrantonio F, Maggi C, Fanetti G, et al. FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. The Oncologist. 2014;19:845–850. - PMC - PubMed
    1. Carr NJ, Sobin LH. Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO Classification of Tumors of the Digestive System. Vol. 3. Lyon, France: International Agency for Research on Cancer; 2010. pp. 93–102.
    1. Misdraji J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms: A clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003;27:1089–1103. - PubMed
    1. Carr NJ, Finch J, Ilesley IC, et al. Pathology and prognosis in pseudomyxoma peritonei: A review of 274 cases. J Clin Pathol. 2012;65:919–923. - PubMed

MeSH terms